Xontogeny Company
Xontogeny seeks to accelerate the development of life science technologies by providing entrepreneurs with the leadership, strategic guidance and operational support necessary to increase the probability of success in early drug and technology development. Through a differentiated approach, the Xontogeny team partners with the founding scientists and entrepreneurs of new ventures to support their vision while allowing a more efficient development model to benefit company founders and early equity holders.
Employee Number:
11-50
Funding Status:
Early Stage Venture
Headquarters:
Boston, Massachusetts, United States
Technology:
Biologics
Estimated Revenue:
Less than $1M
Founded Date:
2016-06-01
Last Funding Type:
Series A
Total Funding:
15000000
Industry:
BioTech